Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma

An increasing number of patients with pancreatic ductal adenocarcinoma (PDAC) have undergone resection after neoadjuvant therapy (NAT). We have reported Area of Residual Tumor (ART) as a useful pathological assessment method to predict patient outcomes after post NAT resection in various cancer type...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Scientific reports 2019-11, Vol.9 (1), p.17145-11, Article 17145
Hauptverfasser:	Okubo, Satoshi, Kojima, Motohiro, Matsuda, Yoko, Hioki, Masayoshi, Shimizu, Yasuhiro, Toyama, Hirochika, Morinaga, Soichiro, Gotohda, Naoto, Uesaka, Katsuhiko, Ishii, Genichiro, Mino-Kenudson, Mari, Takahashi, Shinichiro
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4028/546 692/53/2422 96/63 Adenocarcinoma Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adult Aged Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - pathology Chemoradiotherapy Chemotherapy Chemotherapy, Adjuvant - methods Clinical outcomes Disease-Free Survival Female Humanities and Social Sciences Humans Lymphatic Metastasis - pathology Male Medical prognosis Middle Aged multidisciplinary Multivariate analysis Neoadjuvant Therapy - methods Neoplasm Recurrence, Local Neoplasm, Residual - drug therapy Neoplasm, Residual - pathology Pancreas Pancreatic cancer Pancreatic Neoplasms Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - pathology Pancreaticoduodenectomy - methods Patients Prognosis Science Science (multidisciplinary)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!